Both coil- and plug-assisted retrograde transvenous obliteration (CARTO/PARTO) for the treatment of portal hypertensive variceal bleeding have good long-term survival and clinical outcomes, according ...

North Ward resident Rose Kruze thought she was just dealing with run-of-the-mill headaches after a bad fall last June.

Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its ...

Lungpacer Medical, a leading neurostimulation company committed to advancing therapies that assist patients in overcoming the negative effects of mechanical ventilation (MV), ...

Medical Implants Market Size and Growth medical implants market was valued at US$ 102.52 Bn in 2022 and is forecast to reach a value of US$ ...

The incidence of chronic thromboembolic pulmonary hypertension is 6.5 per million person-years. 22 Applying these incidence rates to the 2000 US White population, approximately 1400 new chronic ...

BOSTON, Feb. 25, 2025 /PRNewswire/ -- CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, announced today that the first patient has been ...

It features a software-controlled system that contracts the diaphragm through transvenous prenic nerve neurostimulation. The company designed AeroNova to achieve ventilation using lower positive ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

bmc.org A patient with a ruptured left sylvian fissure arteriovenous malformation (AVM) treated with primary transvenous Onyx embolization, and angiographically cured, is reported. The patient ...